In Reply We appreciate the thoughts of Ignoffo and Knapp regarding our Viewpoint on overcoming oncology workforce capacity limitations in the US.1 We agree that nurse practitioners and physician assistants have played significant roles in oncology practices for many years. Our intention was to emphasize their critical role and encourage the concept of both increasing their number and their integration into cancer practices as well as stressing the importance of a practice environment with sufficient supporting personnel to allow both them and physicians to practice at the top of their license, something we know is not always the case. There are a number of models of collaborative practice that can accomplish this.2
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Shulman LN, Sheldon LK, Benz EJ. Value of Oncology Pharmacists in the Oncology Health Care Workforce—Reply. JAMA Oncol. 2020;6(7):1121. doi:10.1001/jamaoncol.2020.1291
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: